Overview Request Sample Pages Request Customization Download PDF
You are viewing: US Infection Control Market analysis
Part of: Infection Control Market (Global)

The US Infection Control Market was valued at $7403.3 Million in 2025 and projected to reach to $10042.7 Million by 2030, representing a compound annual growth rate of 6.3%. The US Infection Control Market is positioned for steady expansion through 2030, driven by aging demographics, increasing surgical procedures, and post-pandemic emphasis on infection prevention.

US Infection Control Market Trends and Insights

  • The US market is driven by stringent regulatory requirements, heightened awareness of healthcare-associated infections, and substantial investments in infection prevention infrastructure across hospitals and healthcare facilities.
  • The US continues to lead in adoption of advanced sterilization, disinfection, and personal protective equipment solutions. Growth in the US Infection Control Market through 2030 is supported by aging population demographics, increased surgical procedures, and post-pandemic emphasis on biosecurity protocols.
  • The US healthcare system's focus on reducing hospital-acquired infections and compliance with CDC and OSHA standards accelerates demand for innovative infection control products and services.
  • Hospitals and outpatient facilities in the US are prioritizing comprehensive infection prevention programs, driving sustained market expansion..

Key Market Statistics

  • CAGR (2025-2030) 6.3% CAGR
  • Market Size, 2025 ~USD 7403.3 Million
  • Forecast, 2030 ~USD 10042.7 Million
  • Country US

US Infection Control Market Overview

Market Valuation :

The US Infection Control Market is valued at $7,403.3 million in 2025 and is projected to reach $10,042.7 million by 2030, demonstrating strong growth potential in the American healthcare sector.

Regulatory Compliance Drivers :

Stringent FDA regulations, OSHA standards, and CDC guidelines mandate comprehensive infection prevention protocols across US healthcare facilities, creating sustained demand for advanced infection control solutions.

Healthcare-Associated Infection Awareness :

Heightened awareness of HAIs among US hospitals and healthcare providers is driving significant investments in prevention infrastructure, sterilization equipment, and antimicrobial products to reduce patient safety risks.

Infrastructure Investment Momentum :

Substantial capital investments in US hospital modernization, surgical centers, and long-term care facilities are accelerating adoption of advanced infection control technologies and protocols.

US Infection Control Market Dynamics

  • Healthcare facilities across the nation are prioritizing infection control investments to meet regulatory mandates and improve patient outcomes.
  • The market benefits from continuous innovation in sterilization technologies, antimicrobial solutions, and monitoring systems.
  • Additionally, rising healthcare expenditures and insurance coverage for infection prevention measures support market growth.
  • Hospitals and outpatient surgical centers are increasingly adopting integrated infection control systems to enhance operational efficiency and reduce healthcare-associated infection rates..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The US Infection Control Market is estimated at $7,403.3 million in 2025 and will reach $10,042.7 million by 2030 at a 6.3% CAGR.
    • Regulatory compliance with CDC and OSHA standards in the US drives consistent demand for infection control solutions.
    • The US market benefits from advanced healthcare infrastructure and high adoption rates of sterilization and disinfection technologies.
    • Post-pandemic biosecurity awareness and aging demographics in the US support sustained market growth through 2030.

    Infection Control Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment STERILIZATION CONSUMABLES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 11.4% from 2025 to 2030
    Largest Segment CLEANING & DISINFECTION PRODUCTS (Product & Service)
    Market Size Base Year (Billions) ~USD 77.55 (2025)
    Revenue Forecast (Billions) ~USD 133.05 (2030)
    Segments Covered Product & Service, Type, Product Type, Formulation, Epa Classification

    US Infection Control Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product & Service

    • Cleaning & Disinfection Products
    • Endoscope Reprocessing Products
    • Other Infection Control Products
    • Protective Barriers
    • Sterilization Products & Services

    By Type

    • Biological Indicators
    • Chemical Indicators
    • Cleaning & Disinfection Equipment
    • Contract Sterilization Services
    • Disinfectants
    • Disinfection & Cleaning Accessories
    • Dry Heat Sterilizers
    • E-Beam Sterilization Services
    • Ethylene Oxide (Eto) Sterilizers
    • Eto Sterilization Services
    • Flusher Disinfectors
    • Formaldehyde Sterilizers
    • Gamma Sterilization Services
    • Heat Sterilization Equipment
    • Hydrogen Peroxide Sterilizers
    • Low-Temperature Sterilization Equipment
    • Lubricants & Cleaning Solutions
    • Moist Heat Sterilizers
    • Other Cleaning & Disinfection Equipment
    • Other Contract Sterilization Services
    • Other Low-Temperature Sterilization Equipment
    • Other Sterilization Accessories
    • Radiation Sterilizers
    • Steam Sterilization Services
    • Sterilization Accessories
    • Sterilization Consumables
    • Sterilization Equipment
    • Sterilization Indicators
    • Sterilization Lubricants
    • Sterilization Pouches
    • Ultrasonic Cleaners
    • Uv-Ray Disinfectors
    • Washer Disinfectors

    By Product Type

    • Hand Disinfectants
    • Instrument Disinfectants
    • Skin Disinfectants
    • Surface Disinfectants

    By Formulation

    • Disinfectant Sprays
    • Disinfectant Wipes
    • Liquid Disinfectants

    By Epa Classification

    • High-Level Disinfectants
    • Intermediate-Level Disinfectants
    • Low-Level Disinfectants

    Target Audience

    • Hospital Administrators & C-Suite : Need market data to justify infection control budget allocations, evaluate vendor solutions, and benchmark their facility's infection prevention investments against US industry standards and growth trends.
    • Medical Device & Pharmaceutical Companies : Require US-specific market intelligence to identify growth opportunities, assess competitive positioning, and develop go-to-market strategies for infection control products in American healthcare facilities.
    • Healthcare Consultants & Advisors : Use detailed US market analysis to advise clients on infection prevention strategy, technology adoption, and operational improvements aligned with regulatory requirements and market best practices.
    • Private Equity & Investment Firms : Need validated US market size, growth projections, and sector dynamics to evaluate acquisition targets, assess portfolio company performance, and identify investment opportunities in infection control.
    • Infection Prevention Specialists : Require current US market insights on emerging technologies, regulatory changes, and industry trends to enhance infection control programs, justify resource allocation, and stay informed on best practices.

    Key Companies in the US Infection Control Market

    CompanyHQOwnershipStrongest segments
    COLOPLAST A/SDenmarkPublic CompanyOstomy Care (SenSura Mio, SenSura, Brava accessories),Continence Care (Conveen, SpeediCath, Peristeen portfolio),Advanced Wound Dressings and Biologics (Biatain Silicone, Comfeel),
    STRYKER CORPORATIONUnited StatesPublic CompanyMedSurg and Neurotechnology – Surgical equipment & endoscopy,MedSurg and Neurotechnology – Patient handling, emergency & ICU disposables,MedSurg and Neurotechnology – Neurovascular & stroke/venous therapies,
    AHLSTROM-MUNKSJOFinlandPrivate CompanyFiltration and life sciences,Food and consumer packaging,Protective materials and medical,
    ANSELL LIMITEDAustraliaPublic CompanyHealthcare – surgical and examination gloves,Healthcare – single-use, cleanroom, and sterile garments,Industrial – hand protection (mechanical, cut, impact),
    HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
    JABILUnited StatesPublic CompanyIntelligent Infrastructure (5G, wireless, cloud, networking, storage, digital print and retail),Regulated Industries (healthcare, medical devices, packaging, automotive and transportation),Connected Living and Digital Commerce (connected devices, mobility, digital commerce ecosystem, smart controls and security),
    MOLNLYCKE HEALTH CARESwedenPrivate CompanyAdvanced wound care dressings and prevention solutions,Operating room solutions and procedure packs,Surgical gloves,
    DIVERSEY, INC.United StatesPrivate CompanyInstitutional – cleaning & hygiene chemistry,Institutional – equipment, dosing, and floor care machines,Institutional – services and consulting,
    STERISIrelandPublic CompanySterilization equipment (steam and low-temperature),Washer-disinfectors and automated endoscope reprocessors,Consumables and chemistries,
    RECKITT BENCKISER GROUP PLCUnited KingdomPublic CompanyHealth (OTC, VMS, intimate wellness),Hygiene & Home (germ protection, surface, fabric),Nutrition (infant and young child),
    FORTIVEUnited StatesPublic CompanyIntelligent Operating Solutions – Test & Measurement (FLUKE and related),Intelligent Operating Solutions – Software & Asset/Fleet Platforms (ACCRUENT, GORDIAN, SERVICECHANNEL, INTELEX),Advanced Healthcare Solutions – Sterilization and Infection Prevention (ASP),
    SOTERA HEALTHUnited StatesPublic CompanySterigenics (terminal sterilization and irradiation services),Nordion (Cobalt-60 and gamma systems),Nelson Labs (microbiology, analytical testing, advisory),
    SOLVENTUMUnited StatesPublic CompanyMedsurg,Dental Solutions,Health Information Systems,
    GETINGE ABSwedenPublic CompanyAcute Care Therapies (ICU, ECMO, ventilation, monitoring, drainage, perfusion),Surgical Workflows (OR equipment, anesthesia, OR integration, sterilization, endoscope reprocessing),Life Science (biocontainment, terminal sterilization, isolation, bioprocess and lab solutions),
    ECOLAB, INC.United StatesPublic CompanyGlobal Water,Global Institutional & Specialty,Global Pest Elimination,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, GI devices, services),Surgical Endoscopy Systems & Visualization,Advanced Energy Devices,
    ENVISTAUnited StatesPublic CompanyEquipment & Consumables,Implant Systems & Biomaterials,Orthodontics (Brackets, Wires, Damon, Insignia, AOA),
    PAUL HARTMANN AGGermanyPublic CompanyWound Care,Incontinence Management,Infection Management and Surgical/OT Products,
    KIMBERLY-CLARK CORPORATIONUnited StatesPublic CompanyBaby and child care (diapers, training pants, swimpants, wipes),Adult incontinence and reusable underwear,Feminine care,
    CARDINAL HEALTHUnited StatesPublic CompanyBranded Pharmaceutical Distribution,Generic and OTC Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,
    PROCTER & GAMBLEUnited StatesPublic CompanyFabric & Home Care,Baby, Feminine & Family Care,Beauty,

    COLOPLAST A/S

    Coloplast A/S is a Danish public company founded in 1954 that employs 17,083 people. The company operates in the healthcare and medical devices sector.

    STRYKER CORPORATION

    Stryker Corporation is a United States-based public company founded in 1941 with 56,000 employees. The company is a major player in the medical technology and healthcare industry.

    AHLSTROM-MUNKSJO

    Ahlstrom-Munksjo is a Finnish private company founded in 1851 with 6,883 employees. The company operates in the materials and specialty fiber sectors.

    ANSELL LIMITED

    Ansell Limited is an Australian public company founded in 1893 with 15,000 employees. The company is a global leader in protective solutions and safety products.

    HENRY SCHEIN

    Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a leading distributor of healthcare products and services.

    JABIL

    Jabil is a United States-based public company founded in 1966 with 135,000 employees. The company is a major provider of manufacturing and supply chain solutions.

    MOLNLYCKE HEALTH CARE

    Molnlycke Health Care is a Swedish private company founded in 1849. The company is a global provider of healthcare products and solutions.

    DIVERSEY, INC.

    Diversey, Inc. is a United States-based private company founded in 1923 with 9,000 employees. The company provides cleaning and hygiene solutions for various industries.

    STERIS

    Steris is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and life sciences.

    RECKITT BENCKISER GROUP PLC

    Reckitt Benckiser Group PLC is a United Kingdom-based public company founded in 1819 with 36,200 employees. The company is a global leader in health, hygiene, and home products.

    FORTIVE

    Fortive is a United States-based public company founded in 2015 with 10,000 employees. The company operates in the industrial technology and software sectors.

    SOTERA HEALTH

    Sotera Health is a United States-based public company founded in 2015 with 3,000 employees. The company provides sterilization and contamination control services.

    SOLVENTUM

    Solventum is a United States-based public company founded in 2023 with 20,584 employees. The company operates in the healthcare and industrial technology sectors.

    GETINGE AB

    Getinge AB is a Swedish public company founded in 1904 with 11,754 employees. The company provides medical technology and healthcare solutions globally.

    ECOLAB, INC.

    Ecolab, Inc. is a United States-based public company founded in 1923 with 48,000 employees. The company is a global leader in water, hygiene, and energy technologies.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japan-based public company founded in 1919 with 28,138 employees. The company manufactures precision optical and digital equipment for medical and industrial applications.

    ENVISTA

    Envista is a United States-based public company founded in 2018 with 12,000 employees. The company provides dental products and professional services.

    PAUL HARTMANN AG

    Paul Hartmann AG is a German public company founded in 1818 with 10,066 employees. The company is a leading provider of medical and healthcare products.

    KIMBERLY-CLARK CORPORATION

    Kimberly-Clark Corporation is a United States-based public company founded in 1872 with 36,000 employees. The company is a leading manufacturer of personal care and consumer products.

    CARDINAL HEALTH

    Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees. The company is a major distributor of pharmaceuticals and medical products.

    PROCTER & GAMBLE

    Procter & Gamble is a United States-based public company founded in 1837 with 109,000 employees. The company is a global leader in consumer goods and personal care products.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Confirm the US market opportunity with precise valuation data ($7.4B in 2025) and verified CAGR of 6.3%, enabling accurate financial forecasting and investment decisions for the American healthcare sector.
    • Regulatory Landscape Intelligence : Understand FDA, OSHA, and CDC compliance requirements specific to US infection control, helping healthcare organizations and vendors align products and services with evolving American regulatory standards.
    • Competitive Positioning Strategy : Identify market dynamics, growth drivers, and infrastructure investment trends unique to the US, enabling companies to develop targeted strategies for hospital systems, surgical centers, and long-term care facilities.
    • Investment & Expansion Planning : Leverage detailed US market forecasts through 2030 to guide capital allocation, facility expansion, and product development decisions for healthcare providers and infection control solution manufacturers.
    • Risk Mitigation & Compliance : Access comprehensive insights on US healthcare-associated infection trends and prevention requirements, supporting risk assessment and compliance strategy development for healthcare institutions and vendors.

    Frequently asked questions

    What is the current size of the US Infection Control Market?

    The US Infection Control Market is valued at $7,403.3 million in 2025.

    What is the projected size of the US Infection Control Market by 2030?

    The US Infection Control Market is projected to reach $10,042.7 million by 2030.

    What is the growth rate of the US Infection Control Market?

    The US Infection Control Market is expected to grow at a compound annual growth rate of 6.3% from 2025 to 2030.

    What factors drive growth in the US Infection Control Market?

    Key drivers include stringent regulatory requirements, heightened infection prevention awareness, aging population demographics, increased surgical procedures, and post-pandemic biosecurity emphasis in the US.

    Which regulations impact the US Infection Control Market?

    The US Infection Control Market is significantly influenced by CDC guidelines, OSHA standards, and healthcare facility compliance requirements for infection prevention and control.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics of the infection control sector, including drivers, opportunities, restraints, challenges, and key player strategies. It aims to monitor company developments such as acquisitions, product launches, expansions, agreements, and partnerships among leading players. The competitive landscape is evaluated to assess market players across various parameters within the broad categories of business and product strategy. The market size is estimated using top-down and bottom-up approaches, while market breakdown and data triangulation methods are employed to determine the market size of segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Infection Control Market

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The top-down and bottom-up approaches were used to estimate and validate the total size of infection control. These methods were also used extensively to estimate the size of various market segments. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research.
    • The revenues generated by leading players operating in the infection control industry have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
    Infection Control Market

    Data Triangulation

    After determining the overall market size using the aforementioned process, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides.

    Market Definition

    Infection control refers to eliminating all forms of microorganisms from objects and surfaces to ensure sterility of the object/surface, making it suitable for human use/reuse and avoiding contamination and the spread of diseases. The infection control market encompasses various products & services used for cleaning, disinfecting, and sterilizing objects/surfaces in hospitals & clinics, medical device companies, pharmaceutical companies, and the food and life sciences industries.

    Stakeholders

    • Manufacturers and Distributors of Infection Control Kits and Devices
    • Healthcare Institutes (Hospitals, Laboratories, Medical Colleges, and Outpatient Clinics)
    • Diagnostic Laboratories
    • Pharmaceutical and Biotechnology Companies
    • Trade Associations and Industry Bodies
    • Regulatory Bodies and Government Agencies
    • Research Institutes and Government Organizations
    • Venture Capitalists and Investors
    • Business Research and Consulting Service Providers
    • Market Research and Consulting Firms

    Report Objectives

    • To define, describe, segment, and forecast the global infection control market by products & services, end user, and region
    • To provide detailed information regarding the major factors influencing the global infection control market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall infection control market
    • To analyze the global infection control market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the global infection control market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC countries
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies in the global infection control market
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments in the global infection control market
    • To benchmark players within the global infection control market using the company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

     

    Get the Full Infection Control Market Report

    Full forecast, segment splits, and company analysis for all Infection Control Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status